RAFAEL HOLDINGS, INC. Accounts Receivable, Related Parties
RAFAEL HOLDINGS, INC. (RFL) had Accounts Receivable, Related Parties of $157.00 thousand as of 2023-01-31, per its 10-Q filed 2023-03-14.
Discontinued › Notes › Receivables
us-gaap:AccountsReceivableRelatedParties · last filed 2023-03-14
- 2023-01-31: Accounts Receivable, Related Parties $157.00K.
- 2022-10-31: Accounts Receivable, Related Parties $123.00K.
- 2022-07-31: Accounts Receivable, Related Parties $158.00K.
- 2022-04-30: Accounts Receivable, Related Parties $610.00K.
| Period end | Accounts Receivable, Related Parties |
|---|---|
| 2023-01-31 | $157.00K 10-Q · filed 2023-03-14 |
| 2022-10-31 | $123.00K 10-Q · filed 2022-12-13 |
| 2022-07-31 | $158.00K 10-Q · filed 2023-03-14 |
| 2022-04-30 | $610.00K 10-Q · filed 2022-06-14 |
| 2022-01-31 | $661.00K 10-Q · filed 2022-03-17 |
| 2021-10-31 | $690.00K 10-Q/A · filed 2022-02-28 |
| 2021-07-31 | $113.00K 10-K · filed 2022-10-31 |
| 2020-07-31 | $113.00K 10-Q/A · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |